Related Experiment Video
Updated: Jul 1, 2025

04:11
Author Spotlight: Insights into an Efficient Murine Maxillary Orthodontic Model Protocol
Published on: October 27, 2023
695
SDF-1 involvement in orthodontic tooth movement after tooth extraction
Duangtawan Rintanalert1,2, Yuji Ishida3, Albert Chun-Shuo Huang1
1Department of Orthodontic Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Yushima 1-5-45, Bunkyo-ku, Tokyo, 113-8510, Japan.
Scientific Reports
|February 29, 2024
Summary
Blocking the stromal cell-derived factor 1 (SDF-1)/chemokine receptor type 4 (CXCR4) axis with an antibody reduced tooth movement speed and inflammation. This targeted approach offers potential for controlling orthodontic tooth movement (OTM) and associated bone changes.
Area of Science:
- Biomedical Science
- Orthodontics
- Periodontology
Background:
- The stromal cell-derived factor 1 (SDF-1)/chemokine receptor type 4 (CXCR4) axis is crucial for alveolar bone metabolism during orthodontic tooth movement (OTM).
- Understanding its role is key to modulating OTM velocity and periodontal changes, especially after adjacent tooth extraction.
Purpose of the Study:
- To investigate the effects of the SDF-1/CXCR4 axis on the regional acceleratory phenomenon (RAP) in OTM.
- To evaluate the impact of blocking this axis on periodontal changes following adjacent tooth extraction in a rat model.
Main Methods:
- Rats underwent maxillary first molar extraction and mesial OTM of the second molar using a closed-coil spring.
- Injections of phosphate-buffered saline, IgG isotype control, or anti-SDF-1 antibody were administered locally.
- Analyses of OTM distance, osteoclast activity, and inflammatory markers were performed at 1, 3, and 7 days.
Main Results:
- SDF-1 expression significantly increased post-extraction, which was blocked by anti-SDF-1 antibody.
- Anti-SDF-1 treatment significantly reduced M2 OTM distance and osteoclast numbers on day 3.
- Localized inflammatory markers were also reduced in the experimental group.
Conclusions:
- Serial local injection of anti-SDF-1 neutralizing antibody effectively reduces OTM velocity.
- This intervention also decreases osteoclast accumulation and localized inflammatory responses in OTM with extraction-induced RAP.
- Targeting the SDF-1/CXCR4 axis presents a viable strategy for managing OTM.

